OccluNova is an early-stage, pre-market medical device company. Advanced prototypes exist and have been tested in small studies using a porcine model. Next steps are to formally transfer the technology from the licensee, develop a manufacturing facility, raise Series A financing, test and iterate the device, and initiate a first-in-human study by Q3/4-2024.